Recurrent pregnancy loss
Information
- Disease name
- Recurrent pregnancy loss
- Disease ID
- Description
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| NOP14 | 4 | 2,937,936 | 2,963,406 | 4 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04744025 | Active, not recruiting | N/A | Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates | January 13, 2021 | December 31, 2022 |
| NCT04621773 | Active, not recruiting | Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss | September 1, 2020 | September 1, 2025 | |
| NCT01542411 | Completed | Effectiveness of Aspirin in Compare With Heparin Plus Aspirin in Recurrent Pregnancy Loss Treatment | April 2008 | ||
| NCT00721591 | Completed | Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy | March 2005 | July 2014 | |
| NCT04455256 | Completed | Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss | March 20, 2020 | July 7, 2020 | |
| NCT05802784 | Completed | N/A | Hysteroscopic Septoplasty by Different Modalities | June 16, 2020 | March 21, 2023 |
| NCT04017754 | Completed | Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL) | January 1, 2016 | March 29, 2021 | |
| NCT05073978 | Completed | B-vitamin Levels and Adverse Pregnancy Outcomes | December 1, 2020 | December 31, 2022 | |
| NCT02386384 | Completed | TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure | March 2015 | July 2017 | |
| NCT02572154 | Completed | N/A | Sperm DNA Fragmentation in Recurrent Pregnancy Loss | September 2012 | July 2015 |
| NCT04718233 | Completed | Phase 2 | Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss | September 5, 2018 | July 1, 2019 |
| NCT03401918 | Completed | Phase 2 | Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility | August 1, 2017 | July 1, 2021 |
| NCT05205044 | Completed | Evaluation of Apelin-13 and Apelin-36 in Women With Recurrent Pregnancy Loss | January 23, 2022 | January 30, 2023 | |
| NCT03178682 | Completed | Ultrasound Predictors of Early Pregnancy Failure in Patients With Recurrent Pregnancy Loss | January 1, 2017 | October 1, 2017 | |
| NCT03174951 | Completed | Phase 2 | Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss | September 20, 2016 | June 20, 2017 |
| NCT05342948 | Completed | Association of HY-restricting HLA Class II Alleles, Sex of Firstborn Child, and Pregnancy Outcome in RPL Patients | January 1, 2016 | October 1, 2022 | |
| NCT05520112 | Not yet recruiting | Phase 1/Phase 2 | Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells | November 1, 2022 | December 31, 2023 |
| NCT05612620 | Not yet recruiting | Elucidating the Microbiome in Patients With Recurrent Pregnancy Loss | November 14, 2022 | September 2023 | |
| NCT05167812 | Not yet recruiting | On Pregnancy After Losses - OPAL Study | February 1, 2022 | February 1, 2028 | |
| NCT04701034 | Recruiting | Phase 2 | Intravenous Immunoglobulin and Prednisolone for RPL After ART. | February 6, 2021 | August 1, 2023 |
| NCT05186207 | Recruiting | Establishment of Special Disease Cohort for RPLand Study of Impact Mechanism of Early Embryo Development | January 12, 2022 | December 31, 2024 | |
| NCT06182878 | Recruiting | N/A | Tender Loving Care for Recurrent Pregnancy Loss | January 1, 2024 | December 1, 2025 |
| NCT05656846 | Recruiting | N/A | Biweekly Follow-Up and At-Home Ultrasound Reduce Anxiety in Women With Recurrent Pregnancy Loss | July 15, 2022 | April 1, 2025 |
| NCT05725512 | Recruiting | Phase 4 | Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages | January 29, 2024 | July 29, 2027 |
| NCT05989178 | Recruiting | Prospective Recurrent Pregnancy Loss Registry | July 12, 2022 | December 31, 2032 | |
| NCT06007560 | Recruiting | N/A | Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss | March 21, 2022 | August 2024 |
| NCT05444283 | Recruiting | Genomic Predictors of Recurrent Pregnancy Loss | September 1, 2021 | September 2026 | |
| NCT04397042 | Suspended | SCUBE-1 and Carotid Intima Media Thickness in Recurrent Pregnancy Loss | May 22, 2020 | June 23, 2022 | |
| NCT01546350 | Suspended | Phase 2 | Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH | March 2012 | June 2014 |
| NCT00564174 | Terminated | N/A | Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT | March 2000 | September 2005 |
| NCT05186779 | Terminated | Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy | December 15, 2021 | July 14, 2023 | |
| NCT01325805 | Terminated | N/A | Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss | December 2010 | December 2013 |
| NCT03690830 | Unknown status | N/A | Use of Metabolomics for the Identification of Endometrial Biomarkers for IRPL and RIF After in Vitro Fertilization | January 1, 2019 | January 1, 2021 |
| NCT03671174 | Unknown status | N/A | Immunosuppressant Regimens for Living Fetuses Study | August 2, 2019 | February 2023 |
| NCT01635426 | Unknown status | Phase 2/Phase 3 | Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages | March 2012 | March 2018 |
| NCT03305263 | Unknown status | Phase 3 | Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss | January 25, 2018 | January 2023 |
| NCT05237843 | Unknown status | Phase 1 | Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss | March 1, 2022 | January 2023 |
| NCT05341856 | Unknown status | Early Phase 1 | Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL | May 1, 2022 | September 2022 |
| NCT03214185 | Unknown status | N/A | Effects of PGS2.0 in Patients With Unexplained RPL | February 6, 2018 | September 30, 2021 |
| NCT03106935 | Unknown status | Early Phase 1 | Recurrent Pregnancy Loss and Thyroid Disease | July 2015 | June 2018 |
| NCT02990403 | Unknown status | Phase 4 | The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss | October 2014 | December 22, 2018 |
| NCT02990390 | Unknown status | The Epidemiology of Recurrent Spontaneous Abortion Associated With Thrombophilla | November 2016 | October 2019 | |
| NCT05169541 | Unknown status | Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction | February 2, 2022 | November 30, 2022 | |
| NCT02156063 | Unknown status | Phase 2 | A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL) | June 2014 | June 2016 |
| NCT02144064 | Unknown status | Phase 3 | Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin | June 23, 2019 | December 2022 |
| NCT01946945 | Unknown status | Phase 2 | Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis | September 2013 | |
| NCT03905395 | Unknown status | N/A | Meditation and Mindfulness for Recurrent Pregnancy Loss | February 2, 2019 | June 30, 2020 |
| NCT02379650 | Withdrawn | Phase 2 | Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss | July 2016 | July 2021 |